Lima M F, Kierszenbaum F
J Immunol. 1987 Sep 1;139(5):1647-51.
Human lactoferrin (LF)--a neutrophil glycoprotein, the body fluid levels of which increase in inflammatory conditions--stimulates the phagocytic and cytotoxic properties of macrophages. We found in this work that, whereas the presence of iron in the LF molecule was not required to increase the capacity of mouse peritoneal macrophages (MPM) to take up Trypanosoma cruzi amastigotes (AMA), Listeria monocytogenes, or latex particles, it was necessary for LF to enhance intracellular killing of the two microorganisms. Thus, iron-free human lactoferrin (ApoLF), which did not increase MPM cytotoxicity, after restoration of ferric ions prior to its use in MPM treatments or when ferric citrate was added to the culture medium immediately after ApoLF treatment of the MPM, does increase MPM cytotoxicity. In that iron ions cannot be internalized as such, the latter observation suggested that ApoLF had taken up iron while membrane bound and then enhanced killing. Immunofluorescence studies revealed that comparable proportions of MPM-bound ApoLF or LF at either 20 or 100% iron saturation without appreciable differences in fluorescence intensity. Therefore, reduced binding of ApoLF compared with LF was not a likely explanation for the lack of effect of ApoLF on MPM killing. LF did not enhance AMA killing by MPM in the presence of the iron chelator deferoxamine. Diethylaminetriamine-pentaacetic acid, an iron chelator which is not incorporated into cells, had a similar effect. The iron-binding protein transferrin did not alter the capacity of MPM to either take up or kill the AMA, indicating that the noted LF effects were not shared by all iron-binding proteins. However, prior treatment of MPM with transferrin enabled the cells to display a greater parasite killing capacity after ApoLF treatment, suggesting a role for iron in this activity. Whether iron is required for LF to impart the signal that elicits enhanced killing, to satisfy a biochemical requirement for more effective killing, or both, remains to be clarified. We also found that killing of internalized AMA by LF-treated MPM--previously reported to be mediated in part by H2O2, O2-., and 1O2--was inhibitable by scavengers of OH., and therefore, appears to involve this oxygen metabolite as well.
人乳铁蛋白(LF)是一种中性粒细胞糖蛋白,在炎症状态下其体液水平会升高,它能刺激巨噬细胞的吞噬和细胞毒性特性。我们在这项研究中发现,虽然LF分子中存在铁并非提高小鼠腹腔巨噬细胞(MPM)摄取克氏锥虫无鞭毛体(AMA)、单核细胞增生李斯特菌或乳胶颗粒能力所必需,但LF增强对这两种微生物的细胞内杀伤却是必需的。因此,无铁人乳铁蛋白(ApoLF)在用于MPM处理前恢复三价铁离子或在ApoLF处理MPM后立即向培养基中添加柠檬酸铁时,确实会增加MPM的细胞毒性,而ApoLF本身不会增加MPM的细胞毒性。鉴于铁离子本身无法被内化,后一观察结果表明ApoLF在膜结合时摄取了铁,然后增强了杀伤作用。免疫荧光研究显示,MPM结合的ApoLF或LF在铁饱和度为20%或100%时比例相当,荧光强度无明显差异。因此,与LF相比,ApoLF结合减少不太可能是ApoLF对MPM杀伤缺乏作用的原因。在铁螯合剂去铁胺存在的情况下,LF不会增强MPM对AMA的杀伤作用。二乙三胺五乙酸是一种不被细胞摄取的铁螯合剂,也有类似作用。铁结合蛋白转铁蛋白不会改变MPM摄取或杀伤AMA的能力,这表明并非所有铁结合蛋白都具有上述LF的作用。然而,用转铁蛋白预先处理MPM能使细胞在ApoLF处理后表现出更大的寄生虫杀伤能力,这表明铁在该活性中起作用。铁是LF传递引发增强杀伤信号所必需,还是满足更有效杀伤的生化需求所必需,抑或是两者都必需,仍有待阐明。我们还发现,LF处理的MPM对内化AMA的杀伤作用(此前报道部分由H2O2、O2-.和1O2介导)可被OH.清除剂抑制,因此,似乎也涉及这种氧代谢产物。